{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:16:10Z","timestamp":1770142570504,"version":"3.49.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R01AI139261"],"award-info":[{"award-number":["2R01AI139261"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI141349"],"award-info":[{"award-number":["T32 AI141349"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American College of Clinical pharmacy Foundation Junior Investigator Research","award":["G0507743"],"award-info":[{"award-number":["G0507743"]}]},{"name":"Society of Infectious Diseases Pharmacists Early Career Research","award":["G0507861"],"award-info":[{"award-number":["G0507861"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Reduced vancomycin (VAN) susceptibility in clinical Clostridioides difficile isolates is correlated with poor clinical outcomes. However, factors associated with infection with these strains are unknown. The goal of this study was to determine risk factors for reduced VAN susceptibility among clinical isolates of C. difficile.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This multicenter cohort study included adults with C. difficile infection (CDI) between 2016 and 2021. Clinical C. difficile isolates underwent agar dilution VAN susceptibility testing and ribotyping. Reduced susceptibility was defined as a minimum inhibitory concentration (MIC) &amp;gt; 2\u2005\u00b5g\/mL. Medical charts were reviewed for host, pathogen, and hospital characteristics and assessed for predictors of reduced VAN susceptibility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Five hundred and ninety-four hospitalized patients with CDI between 2016 and 2021 (female: 57%, age &amp;gt;65 years: 55%, White\/non-Hispanic: 59%, nonsevere CDI episode: 53%) were identified. Of 594 isolates, 173 (29%) had reduced VAN susceptibility (MIC50: 2\u2005\u00b5g\/mL, MIC90: 4\u2005\u00b5g\/mL). In multivariable analysis, ribotype (RT) 027 (odds ratio [OR]: 13.4; 95% confidence interval [CI], 7.7\u201323.4; P &amp;lt; .0001) and RT 255 (OR: 2.9; 95% CI, 1.4\u20136.1; P = .005) were positively associated with reduced VAN susceptibility whereas RT 014\u2013020 (OR: 0.41; 95% CI, 0.21\u20130.80; P = .0092) was more likely to be susceptible to VAN. The prevalence of strains with reduced VAN susceptibility increased over time (P = .0163). No patient- or hospitalization-specific variable predicted infection with reduced susceptibility strain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Certain ribotypes, including RT 027, were the sole independent risk factors for reduced VAN susceptibility. Increased clinical surveillance of these strains, especially RT 027, and their antibiotic susceptibly is warranted to inform prescribing practices.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofae588","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T13:55:26Z","timestamp":1728568526000},"source":"Crossref","is-referenced-by-count":5,"title":["Reduced Vancomycin Susceptibility in <i>Clostridioides difficile<\/i> Is Associated With Specific Ribotypes"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6645-406X","authenticated-orcid":false,"given":"Taryn A","family":"Eubank","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy , Houston, Texas ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8884-1298","authenticated-orcid":false,"given":"Chetna","family":"Dureja","sequence":"additional","affiliation":[{"name":"Center of Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center , Houston, Texas ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1906-359X","authenticated-orcid":false,"given":"Anne J","family":"Gonzales-Luna","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy , Houston, Texas ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2214-8105","authenticated-orcid":false,"given":"Julian G","family":"Hurdle","sequence":"additional","affiliation":[{"name":"Center of Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center , Houston, Texas ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2063-7503","authenticated-orcid":false,"given":"Kevin W","family":"Garey","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy , Houston, Texas ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"2024112610424136800_ofae588-B1","doi-asserted-by":"crossref","DOI":"10.15620\/cdc:82532","volume-title":"Antibiotic resistance threats in the United States, 2019","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"2024112610424136800_ofae588-B2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. burden of Clostridioides difficile infection and outcomes","volume":"382","author":"Guh","year":"2020","journal-title":"N Engl J Med"},{"key":"2024112610424136800_ofae588-B3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/cid\/cis386","article-title":"The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999\u20132007","volume":"55","author":"Hall","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2024112610424136800_ofae588-B4","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"key":"2024112610424136800_ofae588-B5","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/cid\/ciaa484","article-title":"Impact of revised Infectious Diseases Society of America and Society for Healthcare Epidemiology of America clinical practice guidelines on the treatment of Clostridium difficile infections in the United States","volume":"72","author":"Clancy","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024112610424136800_ofae588-B6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024112610424136800_ofae588-B7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/antibiotics11020258","article-title":"Genetic mechanisms of vancomycin resistance in Clostridioides difficile: a systematic review","volume":"11","author":"Eubank","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2024112610424136800_ofae588-B8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cid\/ciae087","article-title":"Reduced vancomycin susceptibility in Clostridioides difficile is associated with lower rates of initial cure and sustained clinical response","volume":"79","author":"Eubank","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2024112610424136800_ofae588-B9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.anaerobe.2014.03.002","article-title":"Investigation of potentially pathogenic Clostridium difficile contamination in household environs","volume":"27","author":"Alam","year":"2014","journal-title":"Anaerobe"},{"key":"2024112610424136800_ofae588-B10","volume-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2018","edition":"9th ed"},{"key":"2024112610424136800_ofae588-B11","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2024","edition":"34th ed"},{"key":"2024112610424136800_ofae588-B12","author":"European Committee on Antimicrobial Susceptibility Testing"},{"key":"2024112610424136800_ofae588-B13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/pharma2040024","article-title":"Detectable vancomycin stool concentrations in hospitalized patients with diarrhea given intravenous vancomycin","volume":"2","author":"Eubank","year":"2023","journal-title":"Pharmacoepidemiology"},{"key":"2024112610424136800_ofae588-B14","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2024112610424136800_ofae588-B15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2024112610424136800_ofae588-B16","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024112610424136800_ofae588-B17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/cid\/ciaa912","article-title":"Emergence of clinical Clostridioides difficile isolates with decreased susceptibility to vancomycin","volume":"74","author":"Darkoh","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024112610424136800_ofae588-B18","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N Engl J Med"},{"key":"2024112610424136800_ofae588-B19","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/cid\/ciy782","article-title":"Clostridioides (formerly Clostridium) difficile infection during hospitalization increases the likelihood of nonhome patient discharge","volume":"68","author":"Reveles","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024112610424136800_ofae588-B20","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1128\/AAC.00845-15","article-title":"U.S.-based National Sentinel Surveillance study for the epidemiology of Clostridium difficile-associated diarrheal isolates and their susceptibility to fidaxomicin","volume":"59","author":"Snydman","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2024112610424136800_ofae588-B21","doi-asserted-by":"crossref","first-page":"e00391-19","DOI":"10.1128\/AAC.00391-19","article-title":"U.S.-based national surveillance for fidaxomicin susceptibility of Clostridioides difficile-associated diarrheal isolates from 2013 to 2016","volume":"63","author":"Thorpe","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2024112610424136800_ofae588-B22","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1128\/AAC.02775-13","article-title":"Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013","volume":"58","author":"Tickler","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2024112610424136800_ofae588-B23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/cid\/ciac817","article-title":"Reference susceptibility testing and genomic surveillance of Clostridioides difficile, United States, 2012\u201317","volume":"76","author":"Gargis","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2024112610424136800_ofae588-B24","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/jac\/dkaa118","article-title":"Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017","volume":"75","author":"Karlowsky","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2024112610424136800_ofae588-B25","doi-asserted-by":"crossref","first-page":"e0048922","DOI":"10.1128\/aac.00489-22","article-title":"Influence of binary toxin gene detection and decreased susceptibility to antibiotics among Clostridioides difficile strains on disease severity: a single-center study","volume":"66","author":"Costa","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2024112610424136800_ofae588-B26","doi-asserted-by":"crossref","first-page":"e0034923","DOI":"10.1128\/aac.00349-23","article-title":"A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020\u20132021","volume":"67","author":"Snydman","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"2024112610424136800_ofae588-B27","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3390\/microorganisms10071477","article-title":"Characterization of Clostridioides difficile strains from an outbreak using MALDI-TOF mass spectrometry","volume":"10","author":"Calderaro","year":"2022","journal-title":"Microorganisms"},{"key":"2024112610424136800_ofae588-B28","doi-asserted-by":"crossref","first-page":"102351","DOI":"10.1016\/j.anaerobe.2021.102351","article-title":"MALDI-TOF MS: an alternative approach for ribotyping Clostridioides difficile isolates in Brazil","volume":"69","author":"Carneiro","year":"2021","journal-title":"Anaerobe"},{"key":"2024112610424136800_ofae588-B29","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10096-023-04665-y","article-title":"Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning","volume":"42","author":"Abdrabou","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024112610424136800_ofae588-B30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/cid\/cis614","article-title":"Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England","volume":"55","author":"Wilcox","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2024112610424136800_ofae588-B31","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1017\/ice.2018.230","article-title":"Environmental transmission of Clostridioides difficile ribotype 027 at a long-term care facility; an outbreak investigation guided by whole genome sequencing","volume":"39","author":"Endres","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2024112610424136800_ofae588-B32","doi-asserted-by":"crossref","first-page":"ofx018","DOI":"10.1093\/ofid\/ofx018","article-title":"Community environmental contamination of toxigenic Clostridium difficile","volume":"4","author":"Alam","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2024112610424136800_ofae588-B33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/22221751.2020.1721335","article-title":"PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255","volume":"9","author":"Gonzales-Luna","year":"2020","journal-title":"Emerg Microbes Infect"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae588\/59649974\/ofae588.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/11\/ofae588\/60750957\/ofae588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/11\/ofae588\/60750957\/ofae588.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T10:42:58Z","timestamp":1732617778000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae588\/7816278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae588","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,10,10]]},"article-number":"ofae588"}}